Introduction {#s1}
============

Anion channelrhodopsins (ACRs) are natural light-gated anion channels first discovered in the cryptophyte alga *Guillardia theta* (*Gt*ACR1 and *Gt*ACR2) ([@bib9]). Their large Cl^-^ conductance makes *Gt*ACRs and other ACRs later found in various cryptophyte species ([@bib13]; [@bib12]) the most potent neuron-silencing optogenetic tools available. *Gt*ACRs have proven to be effective inhibitors of neural processes and behavior in flies ([@bib24]; [@bib28]; [@bib34]), worms ([@bib3]), zebrafish ([@bib27]), ferrets ([@bib40]), and mice ([@bib8]; [@bib23]; [@bib26]; [@bib36]).

Of the 35 ACR homologs found in cryptophyte algae ([@bib13]; [@bib10]; [@bib39]), *Gt*ACR1 is the best characterized in terms of its gating mechanism and photochemical reaction cycle ([@bib32]; [@bib33]), and also is the only ACR for which light-gated anion conductance has been proven to be maintained in vitro in a purified state ([@bib20]) further recommending it as the preferred ACR for crystallization. The effects of mutations of several key residues, including E68Q/R, S97E, C102A and D234N, on photocurrents and photochemical conversions of *Gt*ACR1 have been studied in detail ([@bib32]; [@bib33]).

The most closely related molecules to ACRs are cation channelrhodopsins (CCRs) from chlorophyte algae ([@bib11]). The best characterized CCRs are channelrhodopsin-2 (*Cr*ChR2) ([@bib29]), a membrane-depolarizing phototaxis receptor from *Chlamydomonas reinhardtii* ([@bib31]), and C1C2, a chimera of *Cr*ChR2 and its paralog *Cr*ChR1 ([@bib16]). Atomic structures of C1C2 and *Cr*ChR2 have been obtained by X-ray crystallography ([@bib16]; [@bib35]).

The two channelrhodopsin families exhibit large differences in their sequences and photochemistry ([@bib11]): (i) ACRs conduct only anions with complete exclusion of cations, even H^+^, for which CCRs exhibit their highest relative permeability; (ii) ACRs are generally more potent; for example *Gt*ACR1 exhibits 25-fold higher unitary conductance than *Cr*ChR2; (iii) The retinylidene Schiff base in the photoactive site deprotonates prior to channel opening in CCRs ([@bib21]) and, in contrast, in ACRs remains protonated throughout the lifetime of the open-channel state with deprotonation correlated with the initial phase of channel closing ([@bib33]; [@bib39]).

Here, we report the atomic structure of the dark (closed) state of *Gt*ACR1, which is essential for elucidating the mechanism of its unique natural function of light-gated anion conductance through biological membranes. Also, understanding ACR mechanisms at the atomic scale would enable rational engineering to tailor their use as optogenetic tools.

Results and discussion {#s2}
======================

Overall *Gt*ACR1 structure {#s2-1}
--------------------------

The *Gt*ACR1 protein was expressed in insect (Sf9) cells and purified as a disulfide-crosslinked homodimer ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We obtained lipidic cubic phase (LCP) crystals of *Gt*ACR1, applied the continuous grid-scan method ([@bib41]) for X-ray data collection, and determined the structure at 2.9 Å resolution using molecular replacement ([Figure 1](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). Each asymmetric unit contains a *Gt*ACR1 homodimer molecule ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Each monomer is composed of an extracellular cap domain, seven transmembrane helices (TM1-7), and a cytoplasmic loop at the carboxyl-terminus ([Figure 1](#fig1){ref-type="fig"}). In the extracellular domain, two kinked α-helices from the amino-terminal fragment and a β-hairpin from the TM2-3 loop lay on the interface of the membrane domain. The *Gt*ACR1 homodimer is stabilized by TM3 and TM4 interactions between monomers and further by an intermolecular disulfide bridge formed by the C6 residues ([Figure 1A--B](#fig1){ref-type="fig"}). Since TM5-7 are much longer than TM1-4, this dimeric arrangement creates a large funnel-shaped cytoplasmic cavity (\~18 Å deep and \~28 Å wide). Despite the modest \~24% amino acid sequence identity between *Gt*ACR1 and C1C2/*Cr*ChR2, the structure of each *Gt*ACR1 protomer can be superposed well ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) with either of the two CCR structures (r.m.s.d. 0.9 Å) indicating that these functionally distinct channelrhodopsins share a common TM helical scaffold conformation in their closed states.

![Overall structure of the *Gt*ACR1 homodimer.\
Side (**A**), and top (**B**) views. Each *Gt*ACR1 protomer is depicted in cartoon with the N-termini in *blue* and the C-termini in *red*. Retinal prosthetic groups (stick-balls) are embedded in the 7TMs. An intermolecular disulfide bridge is formed by C6 (*yellow* sticks). Resolved monoolein lipids are shown as sticks.](elife-41741-fig1){#fig1}

10.7554/eLife.41741.006

###### Crystallographic data and refinement statistics of the *Gt*ACR1 structure

  -----------------------------------------------------
  PDB ID                      6EDQ
  --------------------------- -------------------------
  Space group                 *P*2~1~2~1~2

  a, b, c (Å)                 77.79, 149.55, 62.41

  α, β. γ (°)                 90, 90, 90

  Beamline                    SLS-X06SA

  Wavelength (Å)              1.0

  Resolution (Å)              47.91--2.9 (2.98--2.9)

  R*meas*                     0.39 (2.65)

  I /σ (I)                    4.54 (0.97)

  Completeness (%)            99.8 (100)

  Multiplicity                6.89 (6.57)

  CC1/2 (%)                   99 (32)

  Refinement                  

  Resolution (Å)              47.91--2.90 (3.08-2.90)

  No. of unique reflections   16711(2732)

  R*work*/R*free*             0.23/0.27

  R.m.s. deviations           

  Bond lengths (Å)            0.005

  Bond angles (°)             0.892

  B-factor                    

  Proteins                    63.8

  Ligands                     80.1

  H~2~O                       51.0

  Ramachandran Plot           

  Favored (%)                 97.56

  Allowed (%)                 2.44

  MolProbity\                 9.39
  Clash score                 
  -----------------------------------------------------

^\*^Data processing statistics are reported with Friedel pairs merged. Values in parentheses are for the highest resolution shell.

The anion conductance pathway {#s2-2}
-----------------------------

A continuous tunnel spanning through the protein from the extracellular to cytoplasmic surface was detected in each *Gt*ACR1 protomer by serial cross-sections ([Figure 2A](#fig2){ref-type="fig"}). The tunnel, assembled by TM1-3 and 7, starts from an electropositive port on the extracellular surface, intersects the retinylidene Schiff base in the middle of the membrane, and ends at an intracellular port deeply embedded in the large dimeric cavity ([Figure 2B](#fig2){ref-type="fig"}).

![The dark state tunnel of *Gt*ACR1.\
(**A**) A cross-section view of the *Gt*ACR1 dimer showing two continuous intramolecular tunnels traversing from extracellular ports to the cytoplasmic cavity; retinal (*green*). (**B**) A cross-section view of a *Gt*ACR1 protomer showing the conformation of the transmembrane ion tunnel and retinal binding pocket connected at the retinylidene Schiff base position. (**C**) The tunnel (dots) detected by CAVER with tunnel-lining residues (sticks): charged (*red*), polar (*cyan*), and apolar residues (*clay*). (**D**) The tunnel profile of *Gt*ACR1 detected by CAVER; the arrows indicate three constrictions C1-C3.](elife-41741-fig2){#fig2}

The continuous intramolecular tunnel in *Gt*ACR1 directly visualized by cross-section, presumably indicating the anion conductance pathway, was also detected by the program CAVER (probe radius 0.9 Å) ([@bib19]) ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). For comparison, only a partial tunnel open on the extracellular side was found in C1C2 ([@bib16]) ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), and we found no tunnel open to either surface with CAVER in *Cr*ChR2.

Despite the high similarity of the TM helix scaffolds of *Gt*ACR1 and C1C2/*Cr*ChR2, the tunnel of *Gt*ACR1 is primarily lined by small polar and aliphatic residues ([Figure 2C](#fig2){ref-type="fig"}) in contrast to charged residues in the corresponding positions in C1C2 and *Cr*ChR2: A75 vs E136/E97 (C1C2/*Cr*ChR2 numbering), T71 vs K132/K93; S97 vs E162/E123, A61 vs E122/E83, and L108 vs H173/H134 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} top row). Tunnel-lining residues also include R94 (R159/R120) and D234 (D292/D253) ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, bottom row), highly conserved in the photoactive sites of microbial rhodopsins, and E68 (E129/E90), characteristic of both ACRs and chlorophyte CCRs. The differences in *Gt*ACR1 from the CCR structures significantly reduce the negativity of the putative channel pore lining consistent with anion vs. cation conductance.

The extracellular port cap {#s2-3}
--------------------------

A unique structural feature is found in the extracellular domain of *Gt*ACR1. In addition to the disulfide link between the two protomers, an intraprotomer disulfide bridge is formed between C21 from the amino-terminal segment and C219 within the TM6-7 loop ([Figure 3A](#fig3){ref-type="fig"}). This intramolecular crosslink immobilizes the kinked helices to the retinal-conjugated TM7, and encaps a hydrophobic part of the segment on the extracellular tunnel entry port ([Figure 3B](#fig3){ref-type="fig"}). Disrupting this extracellular loop conformation, either by truncation of the amino-terminal loop (Δ1--25) or by substituting C21 and C219 with serine to abolish the intramolecular disulfide, resulted in slowed channel closing ([Figure 3C](#fig3){ref-type="fig"}). Both C21 and C219 are highly conserved in ACRs ([@bib12]), but not in CCRs, revealing a role of this intramolecular disulfide bridge specific to the ACR family.

![Features of the ion pathway of *Gt*ACR1.\
(**A**) The N-terminal extracellular loop (*orange*) immobilized by an intracellular C21-C219 disulfide bridge (*red*) to the TM6-7 loop (*blue*); an H-bond network (*black* dashed lines) formed by residues (sticks) near the extracellular port. (**B**) The hydrophobic segment (*orange*) blocks the extracellular port rendered by the electrostatic potential surface. Rectangle: closer (rotated) view of the peptide cap conformation. (**C**) Decay kinetics of laser flash-evoked photocurrents by the wild-type *Gt*ACR1 and indicated mutants. (**D--F**) The structure of the three constrictions: C1 (**D**), C2 (**E**), and C3 (**F**). (**G**) Peak photocurrents generated by Glu substitutions of the constriction residues in response to a 1 s light pulse (515 nm, 7.7 mW mm^−2^) with 131 mM Cl^-^ in the pipette and 6 mM Cl^-^ in the bath. The black squares, mean; line, median; box, SE; whiskers, SD; empty diamonds, raw data recorded from individual cells.\
10.7554/eLife.41741.020Figure 3---source data 1.Numerical data for the current amplitude values measured in individual cells are shown in [Figure 3G](#fig3){ref-type="fig"}.\
10.7554/eLife.41741.021Figure 3---source data 2.Numerical data for the reversal potential values measured in individual cells are shown in [Figure 3---figure supplements 4](#fig3s4){ref-type="fig"} and [6](#fig3s6){ref-type="fig"}.\
10.7554/eLife.41741.022Figure 3---source data 3.Numerical data for the reversal potential values measured in individual cells are shown in [Figure 3---figure supplement 9A](#fig3s9){ref-type="fig"}.\
10.7554/eLife.41741.023Figure 3---source data 4.Numerical data for the reversal potential values measured in individual cells are shown in [Figure 3---figure supplement 9B](#fig3s9){ref-type="fig"}.](elife-41741-fig3){#fig3}

Ion pathway constrictions {#s2-4}
-------------------------

The intramolecular tunnel in *Gt*ACR1 is constricted at three positions: at the extracellular port (C1), near the photoactive retinylidene Schiff base (C2), and at the cytoplasmic side (C3) ([Figures 2D](#fig2){ref-type="fig"} and [3D--F](#fig3){ref-type="fig"}). Near the extracellular port, the C1 constriction ([Figure 3D](#fig3){ref-type="fig"}) is stabilized by an H-bond network adjacent to the disulfide-immobilized extracellular cap and formed by the side chains of Y81, R94 and E223 ([Figure 3A](#fig3){ref-type="fig"}). The mutation R94A nearly abolished Cl^-^ conductance (Figure 5D). To analyze the influence of mutations on channel kinetics, we used laser flash excitation (single-turnover conditions), because under continuous light a mixture of intermediates is formed, the composition of which depends on the intensity and duration of illumination that may influence the kinetics. Channel closing in the wild-type *Gt*ACR1 is biphasic ([@bib32]). As shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and reported earlier for the E223Q mutant ([@bib32]), all three mutations strongly slowed the slow decay phase to a similar extent as that observed in the C21S_C219S mutant. These results suggest that the combination of the H-bond network of E223 and its neighbouring intraprotomer disulfide bridge controls the rate of channel closing in the extracellular region and stabilizes the essential residue R94 in the closed state.

The narrowest constriction C2 lies at the photoactive site and is formed by the side chains of T101, L64, and M105 ([Figure 3E](#fig3){ref-type="fig"}). Four of the five residues that form the intracellular constriction C3 (L108, A61, E60, L245 and P58) ([Figure 3F](#fig3){ref-type="fig"}) are in corresponding positions as the residues that form the 'intracellular gate' in CCRs ([@bib5]), but in *Gt*ACR1 and other ACRs only E60 (E121/E82) is shared with CCRs. The *Gt*ACR1 structure that we obtained from dark-grown crystals is presumably the dark (closed) state of the channel protein. To examine the role of these contriction-forming residues in the channel open state, we scanned the tunnel constrictions with Glu substitutions and measured photocurrents in the respective mutants. We chose Glu as a substituent because two of the constriction residues, A61 and A75, correspond to the highly conserved Glu residues in CCRs (E122/E83 and E136/E97 in C1C2/*Cr*ChR2, respectively), and because neutralization of E83 was required for elimination of the residual H^+^ permeability in Cl^-^-conducting CCR mutants ([@bib4]; [@bib38]). We also hypothesized that the bulky negatively charged Glu side chain would block the *Gt*ACR1 channel when placed in the ion conduction pathway. Indeed, perturbation of any residues at C2 or C3 greatly reduced or eliminated the photocurrents, while effects of most mutations (except A75E) at the C1 position were negligible ([Figure 3G](#fig3){ref-type="fig"}), suggesting that in the open conformation the channel is wider in the extracellular portion and more narrow in its central and intracellular stretches. Kinetically, the mutations of the C1 and C3 residues mostly affected the slow phase of channel closing, making it slower than that in the wild-type ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Accurate kinetic analysis of the C2 mutations was not possible because of their greatly reduced photocurrents.

To test whether the mutations of the constriction residues compromised permeability of the channel for Cl^-^, we partially replaced this ion in the bath with non-permeable aspartate ([@bib9]) and measured the current-voltage relationships (IE curves) ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}) to determine the reversal potentials (E~rev~). None of the mutants in which photocurrents near the reversal potential could be resolved from the background noise yielded E~rev~ values that were statistically significantly different from that measured in the wild type ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}; full statistical results are in [Table 2](#table2){ref-type="table"}). Several other mutations were recently reported to shift the E~rev~ under Cl^-^ gradient conditions from the Cl^-^ Nernst potential ([@bib17]; [@bib18]). However, we found no such change when we tested seven of these single and double mutants ([Figure 3---figure supplements 5](#fig3s5){ref-type="fig"} and [6](#fig3s6){ref-type="fig"}; full statistical results are in [Table 2](#table2){ref-type="table"}). The shifts were attributed to disrupting anion selectivity in *Gt*ACR1 by the mutations resulting in cation permeability ([@bib17]; [@bib18]). Therefore, we further tested these mutants in the presence of H^+^ and Na^+^ gradients ([Figure 3---figure supplements 7](#fig3s7){ref-type="fig"} and [8](#fig3s8){ref-type="fig"}, respectively) and again found no statistically significant difference from the wild type ([Figure 3---figure supplement 9](#fig3s9){ref-type="fig"}; full statistical results are in [Tables 3](#table3){ref-type="table"} and [4](#table4){ref-type="table"}), indicating that none of these mutations produced permeability for these cations in *Gt*ACR1.

10.7554/eLife.41741.024

###### The output of Kriskal-Wallis ANOVA analysis of the results shown in [Figure 3---figure supplements 4](#fig3s4){ref-type="fig"} and [6](#fig3s6){ref-type="fig"}

  X-Function    Kruskal-Wallis ANOVA                                                                 
  ------------- ------------------------------ ------------------------- ---------- -------- ------- -----
  Data filter   No                                                                                   
  Variant       Data                           Range (number of cells)                               
  WT            \[DataAsp\]Sheet1!WT           \[1\*:10\*\]                                          
  Y81E          \[DataAsp\]Sheet1!Y81E         \[1\*:7\*\]                                           
  I27E          \[DataAsp\]Sheet1!I27E         \[1\*:7\*\]                                           
  K33E          \[DataAsp\]Sheet1!K33E         \[1\*:8\*\]                                           
  L108E         \[DataAsp\]Sheet1!L108E        \[1\*:7\*\]                                           
  A61E          \[DataAsp\]Sheet1!A61E         \[1\*:5\*\]                                           
  L245E         \[DataAsp\]Sheet1!L245E        \[1\*:8\*\]                                           
  P58E          \[DataAsp\]Sheet1!P58E         \[1\*:7\*\]                                           
  Q46A          \[DataAsp\]Sheet1!Q46A         \[1\*:13\*\]                                          
  K188A         \[DataAsp\]Sheet1!K188A        \[1\*:8\*\]                                           
  K188E         \[DataAsp\]Sheet1!K188E        \[1\*:7\*\]                                           
  R192E         \[DataAsp\]Sheet1!R192E        \[1\*:9\*\]                                           
  Q46AK188A     \[DataAsp\]Sheet1!Q46AK188A    \[1\*:8\*\]                                           
  K188AR192A    \[DataAsp\]Sheet1!K188AR192A   \[1\*:7\*\]                                           
  K188AR259A    \[DataAsp\]Sheet1!K188AR259A   \[1\*:7\*\]                                           
  Variant       N                              Min                       Q1         Median   Q3      Max
  WT            10                             61                        70         75.5     90.25   93
  Y81E          7                              71                        73         77       85      85
  I27E          7                              75                        77         84       86      86
  K33E          8                              70                        73.75      80       85.75   87
  L108E         7                              69                        72         75       76      82
  A61E          5                              69                        71         74       80      80
  L245E         8                              71                        73.25      75.5     85      91
  P58E          7                              63                        70         75       84      89
  Q46A          13                             69                        74         83       90.5    96
  K188A         8                              78                        78         80       82.5    83
  K188E         7                              75                        76         79       81      83
  R192E         9                              75                        78.5       80       81.5    86
  Q46AK188A     8                              73                        76.75      79       82.25   84
  K188AR192A    7                              68                        74         82       84      88
  K188AR259A    7                              76                        79         84       90      92
  Variant       N                              Mean Rank                 Sum Rank                    
  WT            10                             49.55                     495.5                       
  Y81E          7                              55.71429                  390                         
  I27E          7                              74.28571                  520                         
  K33E          8                              62.8125                   502.5                       
  L108E         7                              31                        217                         
  A61E          5                              36.4                      182                         
  L245E         8                              50.125                    401                         
  P58E          7                              47.64286                  333.5                       
  Q46A          13                             70.30769                  914                         
  K188A         8                              65.9375                   527.5                       
  K188E         7                              58.14286                  407                         
  R192E         9                              66.72222                  600.5                       
  Q46AK188A     8                              59.25                     474                         
  K188AR192A    7                              66.5                      465.5                       
  K188AR259A    7                              84.42857                  591                         
  Chi-Square    DF                             Prob \> Chi-Square                                    
  16.94395      14                             0.25918                                               

Null Hypothesis: The samples come from the same population.

Alternative Hypothesis: The samples come from different populations.

At the 0.05 level, the populations are NOT significantly different.

10.7554/eLife.41741.025

###### The output of Kriskal-Wallis ANOVA analysis of the results shown in [Figure 3---figure supplement 9A](#fig3s9){ref-type="fig"}

  X-Function   Kruskal-Wallis ANOVA                                                                  
  ------------ ------------------------------- ------------------------- ---------- -------- ------- ------
  Variant      Data                            Range (number of cells)                               
  WT           \[DatapH54\]Sheet1!WT           \[1\*:5\*\]                                           
  Q46A         \[DatapH54\]Sheet1!Q46A         \[1\*:7\*\]                                           
  K188A        \[DatapH54\]Sheet1!K188A        \[1\*:6\*\]                                           
  K188E        \[DatapH54\]Sheet1!K188E        \[1\*:8\*\]                                           
  R192E        \[DatapH54\]Sheet1!R192E        \[1\*:10\*\]                                          
  Q46AK188A    \[DatapH54\]Sheet1!Q46AK188A    \[1\*:7\*\]                                           
  K188AR192A   \[DatapH54\]Sheet1!K188AR192A   \[1\*:7\*\]                                           
  K188AR259Q   \[DatapH54\]Sheet1!K188AR259Q   \[1\*:7\*\]                                           
  Variant      N                               Min                       Q1         Median   Q3      Max
  WT           5                               −7.7                      −6.7       −5.7     −3.2    −2.7
  Q46A         7                               −8.7                      −6.7       −5.7     −3.7    −2.7
  K188A        6                               −8.7                      −6.45      −4.7     −3.95   −1.7
  K188E        7                               −9.7                      −4.7       −3.7     −2.7    −2.7
  R192E        8                               −9.7                      −6.45      −4.2     −2.2    −0.7
  Q46AK188A    7                               −8.7                      −6.7       −4.7     −3.7    −2.7
  K188AR192A   7                               −10.7                     −7.7       −4.7     −2.7    −1.7
  K188AR259Q   7                               −11.7                     −4.7       −1.7     0.3     2.3
  Variant      N                               Mean Rank                 Sum Rank                    
  WT           5                               24.4                      122                         
  Q46A         7                               21.71429                  152                         
  K188A        6                               24.75                     148.5                       
  K188E        7                               30.5                      213.5                       
  R192E        8                               28.875                    231                         
  Q46AK188A    7                               24.85714                  174                         
  K188AR192A   7                               25.21429                  176.5                       
  K188AR259Q   7                               38.21429                  267.5                       
  Chi-Square   DF                              Prob \> Chi-Square                                    
  5.33505      7                               0.61915                                               

Null Hypothesis: The samples come from the same population.

Alternative Hypothesis: The samples come from different populations.

At the 0.05 level, the populations are NOT significantly different.

10.7554/eLife.41741.026

###### The output of Kriskal-Wallis ANOVA analysis of the results shown in [Figure 3---figure supplement 9B](#fig3s9){ref-type="fig"}

  X-Function    Kruskal-Wallis ANOVA                                                                      
  ------------- ----------------------------------- ------------------------- ---------- -------- ------- -----
  Data filter   No                                                                                        
  Variant       Data                                Range (number of cells)                               
  WT            \[DataNa1PipNa\]Sheet1!WT           \[1\*:11\*\]                                          
  Q46A          \[DataNa1PipNa\]Sheet1!Q46A         \[1\*:6\*\]                                           
  K188A         \[DataNa1PipNa\]Sheet1!K188A        \[1\*:10\*\]                                          
  K188E         \[DataNa1PipNa\]Sheet1!K188E        \[1\*:6\*\]                                           
  R192E         \[DataNa1PipNa\]Sheet1!R192E        \[1\*:8\*\]                                           
  Q46AK188A     \[DataNa1PipNa\]Sheet1!Q46AK188A    \[1\*:7\*\]                                           
  K188AR192A    \[DataNa1PipNa\]Sheet1!K188AR192A   \[1\*:8\*\]                                           
  K188AR259Q    \[DataNa1PipNa\]Sheet1!K188AR259Q   \[1\*:10\*\]                                          
  Variant       N                                   Min                       Q1         Median   Q3      Max
  WT            11                                  −11                       -9         -5       -3      0
  Q46A          6                                   −11                       −8.75      −2.5     −0.5    1
  K188A         10                                  -9                        −5.5       -4       -4      -2
  K188E         6                                   −14                       −12.5      −6.5     −3.75   -3
  R192E         8                                   -7                        −6.75      -5       −2.5    -2
  Q46AK188A     7                                   -9                        -9         -5       -3      1
  K188AR192A    8                                   −16                       −13.25     -4       −0.5    7
  K188AR259Q    10                                  −15                       −9.25      −7.5     -5      -3
  Variant       N                                   Mean Rank                 Sum Rank                    
  WT            11                                  34.13636                  375.5                       
  Q46A          6                                   43.33333                  260                         
  K188A         10                                  37                        370                         
  K188E         6                                   26.33333                  158                         
  R192E         8                                   36.75                     294                         
  Q46AK188A     7                                   35.5                      248.5                       
  K188AR192A    8                                   35.3125                   282.5                       
  K188AR259Q    10                                  22.25                     222.5                       
  Chi-Square    DF                                  Prob \> Chi-Square                                    
  6.6454        7                                   0.46671                                               

Null Hypothesis: The samples come from the same population.

Alternative Hypothesis: The samples come from different populations.

At the 0.05 level, the populations are NOT significantly different.

The retinylidene Schiff base {#s2-5}
----------------------------

Confocal near-infrared resonance Raman spectroscopy has shown that the unphotolyzed state of *Gt*ACR1 contains almost exclusively all-*trans* retinal ([@bib43]). In the middle of the protein, all*-trans*-retinal covalently bound by a Schiff base linkage to K238 is found in an elongated cavity formed by conserved hydrophobic residues. While the conformations of the retinal polyene chain are nearly identical in *Gt*ACR1 and C1C2/*Cr*ChR2, the presence of F160 in *Gt*ACR1 (G224/G185 in C1C2/*Cr*ChR2, respectively) pushes the β-ionone ring towards the extracellular side by 1.2 Å ([Figure 4](#fig4){ref-type="fig"}). Despite this conformational difference, the action spectrum of photocurrents generated by the F160G mutant was almost identical to that of the wild-type *Gt*ACR1 ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

![The retinal conformation.\
The structure of *Gt*ACR1 (*magenta*) is superimposed with C1C2 (*green*) and *Cr*ChR2 (*blue*) using SSM. The presence of F160 in *Gt*ACR1 (G224/G185 in C1C2/*Cr*ChR2, respectively) pushes the β-ionone ring of the all-*trans* retinal towards the extracellular side by 1.2 Å as measured between the C16 atoms of *Gt*ACR1 and *Cr*ChR2.](elife-41741-fig4){#fig4}

Remarkable structural differences between *Gt*ACR1 and the two crystallized CCRs are found in the retinylidene Schiff base environment. In C1C2 and *Cr*ChR2 the protonated Schiff base (PSB) participates in a quadruple salt-bridge network formed with D292/D253, E162/E123 and K132/K93 sidechains ([Figure 5B](#fig5){ref-type="fig"}). However, this strong network is absent in the *Gt*ACR1 structure due to the replacement of E162/E123 and K132/K93 with smaller uncharged residues S97 and T71, respectively ([Figure 5A](#fig5){ref-type="fig"}). D234 is the only residue directly interacting with the protonated Schiff base (PSB) in *Gt*ACR1, and its electrostatic interaction appears to be weakened by two H-bonds from tyrosine residues Y72 and Y207 ([Figure 5A](#fig5){ref-type="fig"}). The proton pump bacteriorhodopsin exhibits similar tyrosinyl H-bond-weakened interactions of D212, the residue in the corresponding position as D234. The interactions prevent D212 from accepting the Schiff base proton, which is transferred instead to D85 in the proton release pathway ([@bib22]). Resonance Raman and UV-vis absorption spectra of the D234N mutant of *Gt*ACR1 indicate that D234 is similarly neutral and not a Schiff base proton acceptor ([@bib33]; [@bib43]). The dark structure therefore may explain the persistence of protonation of the Schiff base throughout the lifetime of the open channel conformation in *Gt*ACR1. Of the two tyrosine residues, Y207 appeared to be more important functionally, as its replacement with phenylalanine suppressed the photocurrents to a greater extent than that of Y72 ([Figure 5D](#fig5){ref-type="fig"}) and caused a 12 nm blue shift of the action spectrum ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The Y72F mutation mostly affected the slow decay phase, while the Y207F mutation caused a strong perturbation of both phases ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

![Conformation of the Schiff base region of *Gt*ACR1.\
(**A--B**) Structural comparison shows different H-bond networks (*dashed* lines) in *Gt*ACR1 (**A**) and C1C2 (**B**). (**C**) the H-bond network in the ENS triad of *Gt*ACR1. The tunnel (*black* dots) assessed by CAVER. (**D**) Peak photocurrents generated by the wild-type *Gt*ACR1 and indicated mutants in response to laser flash excitation. The black squares, mean; line, median; box, SE; whiskers, SD; empty diamonds, raw data recorded from individual cells.\
10.7554/eLife.41741.034Figure 5---source data 1.Numerical data for the current amplitude values measured in individual cells are shown in [Figure 5D](#fig5){ref-type="fig"}.](elife-41741-fig5){#fig5}

In *Cr*ChR2, photoisomerization of the Schiff base rapidly disrupts the strong salt-bridged network by inducing transfer of the Schiff base proton to D253 or E123 in \~10 µs prior to channel opening ([@bib21]). In contrast, the Schiff base remains protonated throughout the lifetime of the open channel conformation in *Gt*ACR1, and deprotonation of the Schiff base proton occurs late in the photocycle (\~20 ms) correlated with fast channel closing ([@bib33]). Unlike in the salt-bridge network around the Schiff base in the CCRs ([Figure 5B](#fig5){ref-type="fig"}), in *Gt*ACR1 no immediate proton accepting residue is available in the vicinity of the PSB and therefore later structural changes are required to enable Schiff base proton transfer, possibly to E68 ([Figure 5A](#fig5){ref-type="fig"}).

The location of the PSB, centered within the anion path in *Gt*ACR1, suggests that it may play a direct role in anion translocation in the open channel state. Consistent with this idea is that the PSB is only partially neutralized by its D234 counterion because the counterion is weakened by its interaction with the two tyrosinyl residues. Therefore, the PSB presents a partial positive charge capable of transient reversible interaction with Cl^-^ ions in a channel that is largely lined by small polar and hydrophobic aliphatic residues. Supporting a possible direct role of the PSB in the channel's permeability for anions, late deprotonation of the Schiff base after channel opening occurs in all three ACRs so far examined: *Gt*ACR1 and *Gt*ACR2 ([@bib33]) and *Psu*ACR1 ([@bib39]), yet Schiff base deprotonation after channel opening is not known to occur in any CCR. Further indicating an essential role of the protonated Schiff base form, the mutant S97E, in which a potential Schiff base proton acceptor is placed at the corresponding position in *Gt*ACR1 as in CCRs and many other microbial rhodopsins, exhibits (i) appearance of fast Schiff base deprotonation, and (ii) a \> 30 fold suppression of the amplitude of the chloride photocurrent ([@bib33]). Furthermore, the double mutation Y207F/Y72F, expected to release inhibition of D234 as a proton acceptor, decreased the photocurrent amplitude to a negligible value ([Figure 5D](#fig5){ref-type="fig"}).

The ENS triad {#s2-6}
-------------

E68, a glutamyl residue near the Schiff base constriction in the channel, forms an H-bond network with N239 and S43 ([Figure 5C](#fig5){ref-type="fig"}) with a geometry similar to that of a homologous triad (E129/E90, N297/N258, and S102/S63) referred to as 'the central gate' in C1C2 and *Cr*ChR2. In the CCRs, the triad blocks the cation path from the extracellular bulk phase ([@bib5]) and the glutamyl residue contributes to cation selectivity over anions ([@bib37]). In contrast, in *Gt*ACR1 the ENS triad does not occlude the tunnel ([Figure 5C](#fig5){ref-type="fig"}), but E68 is functionally important in channel gating and may serve as a Schiff base proton acceptor at least at basic pH ([@bib32]). The three residues in the ENS triad appear to have distinct roles; that is the substitution S43A had little effect on Cl^-^ conductance, whereas the mutation N239A nearly eliminated the photocurrent ([Figure 5D](#fig5){ref-type="fig"}). Both S43A and N239A mutations decreased the rate of the slow channel closing, but N239A in addition strongly accelerated the fast decay ([Figure 5---figure supplement 3A](#fig5s3){ref-type="fig"}). Remarkably, combining the N239A mutation with the D234N mutation which alone also accelerated the fast decay, returned the channel closing kinetics almost to that of the wild type ([Figure 5---figure supplement 3B](#fig5s3){ref-type="fig"}). Given its location between C2 and C3, N239 may assist moving anions between the Schiff base and the cytoplasmic port ([Figure 2C](#fig2){ref-type="fig"}). Additionally, the distribution of apolar residues in this portion of the channel would also facilitate quick movements of anions as has been proposed for the CLC channel ([@bib30]).

Despite the large phylogenetic difference between cryptophyte ACRs and chlorophyte CCRs, their helical scaffolds are little changed. However, the *Gt*ACR1 structure reveals fundamentally different chemistry built within their common scaffold. The preexisting full-length tunnel, the location of the retinylidene photoactive site directly in the ion path, the maintenance of a net positive charge on the site's Schiff base in a largely neutral tunnel, and the novel extracellular cap, provide important clues to the structural basis of light-gated anion conductance.

Comparison with the recently published *Gt*ACR1 structure {#s2-7}
---------------------------------------------------------

We report the atomic structure of the 7-helix rhodopsin domain (residues 1--295) that contains the light-gated channel activity of *Gt*ACR1. After this manuscript was prepared for submission, an article reporting a structure of the same domain with a short truncation (PDB code: 6CSM, residues 1--282) appeared from Karl Deisseroth and coworkers ([@bib18]).

The two *Gt*ACR1 structures were both determined at 2.9 Å resolution using the lipid cubic phase crystallization method. However, they were obtained in different crystallization conditions and exhibit different space groups and crystal packing. Nevertheless, the two show an extremely high similarity with a marginal RMSD value of \~0.4 Å. All seven transmembrane helices are very well superimposed between the two structures ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). The truncation or different crystal packing did not give rise to any large differences between the two protein structures. Therefore, these two structures presented by two independent groups mutually validate the conformation of *Gt*ACR1 in the closed state.

Differences between our study and that of [@bib18] are primarily in the methods used to deduce the location of the anion conduction pathway in *Gt*ACR1 and the results of testing relative ionic permeabilities of the mutants. By examining the structure by serial cross-sectioning we identified a contiguous intramolecular tunnel from the extracellular to intracellular surfaces. The CAVER algorithm confirmed the tunnel and helped identify three constrictions. Beyond the electropositive extracellular port the tunnel is lined primarily by small polar and aliphatic residues with sparse positive regions, one of them the protonated retinylidene Schiff base itself. Kim et al. described the putative ion conduction pathway in *Gt*ACR1 by identifying intramolecular cavities (vestibules) with electropositive surfaces, which led to identification of mostly residues present in the tunnel walls. Deeper understanding of the foundations of anion conductance by ACRs will likely require an atomic structure of the open state conformation.

Regarding anion selectivity of the mutants, a difference between our study and that of Kim et al.'s is that we have found no detectable cation permeability in any so far examined mutants ([Figure 3---figure supplements 3](#fig3s3){ref-type="fig"}--[9](#fig3s9){ref-type="fig"}). We attribute the strict selectivity for anions, a notable property of ACRs, to the existence of multiple highly selective portions of the tunnel and its two entry/exit ports. Consistent with this view, Kim et al. also concluded that there are multiple selective regions rather than a single selectivity filter, in contrast to CCRs, in which cation selectivity can be weakened to allow partial anion permeability by mutation of even a single residue ([@bib37]).

Overall, the independent analyses of the structures by both groups provide complimentary information creating a firm basis for elucidating the functional mechanism and for further optimization of *Gt*ACR1 as a potent neuron-silencing optogenetic tool.

Materials and methods {#s3}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation                        Source or reference   Identifiers                                                     Additional\
  (species) or resource                                                                                                                            information
  ----------------------- ---------------------------------- --------------------- --------------------------------------------------------------- -----------------------------------------------------------------
  Gene\                   *Gt*ACR1                           Synthetic             GenBank:\                                                       
  (*Guillardia theta*)                                                             KP171708                                                        

  Cell line\              Sf9                                Sigma Aldrich         Sigma Aldrich:\                                                 
  (*Spodoptera*\                                                                   89070101,\                                                      
  *frugiperda*)                                                                    RRID:[CVCL_0549](https://scicrunch.org/resolver/CVCL_0549)      

  Cell line\              HEK293                             ATCC                  ATCC:\                                                          
  (*Homo sapiens*)                                                                 CRL-1573,\                                                      
                                                                                   RRID:[CVCL_0045](https://scicrunch.org/resolver/CVCL_0045)      

  Recombinant\            Cellfectin II Reagent              Thermo Fisher         Cat. No.: 10362100                                              <https://www.thermofisher.com/order/catalog/product/10362100>
  DNA reagent                                                                                                                                      

  Recombinant\            ScreenFectA transfection reagent   Waco Chemicals USA    Cat. No.: 299--73203                                            <http://www.e-reagent.com/uh/Shs.do?now=1544459665328>
  DNA reagent                                                                                                                                      

  Recombinant\            pFastbac1                          Thermo Fisher         Cat. No.: 10360014                                              <https://www.thermofisher.com/order/catalog/product/10360014>
  DNA reagent                                                                                                                                      

  Recombinant\            pcDNA3.1                           Thermo Fisher         Cat. No.: V79020                                                <https://www.thermofisher.com/order/catalog/product/V79020>
  DNA reagent                                                                                                                                      

  Software,\              Pymol                              PyMOL Molecular\      RRID:[SCR_000305](https://scicrunch.org/resolver/SCR_000305)    <http://www.pymol.org/>
  algorithm                                                  Graphics System,\                                                                     
                                                             Schrödinger, LLC                                                                      

  Software,\              UCSF Chimera                       UCSF Resource for\    RRID: [SCR_004097](https://scicrunch.org/resolver/SCR_004097)   <http://plato.cgl.ucsf.edu/chimera/>
  algorithm                                                  Biocomputing,\                                                                        
                                                             Visualization, and\                                                                   
                                                             Bioinformatics                                                                        

  Software,\              PHENIX                             PMID: 20124702        RRID: [SCR_014224](https://scicrunch.org/resolver/SCR_014224)   <http://www.phenix-online.org/>
  algorithm                                                                                                                                        

  Software,\              Coot                               PMID: 15572765        RRID: [SCR_014222](https://scicrunch.org/resolver/SCR_014222)   <http://www.biop.ox.ac.uk/coot/>
  algorithm                                                                                                                                        

  Software,\              OriginPro 2016                     OriginLab                                                                             <https://originlab.com>
  algorithm                                                                                                                                        

  Software,\              pClamp 10                          Molecular Devices     RRID:[SCR_011323](https://scicrunch.org/resolver/SCR_011323)    <http://www.moleculardevices.com/products/software/pclamp.html>
  algorithm                                                                                                                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Gt*ACR1 expression from insect cells and purification {#s3-1}
------------------------------------------------------

*Gt*ACR1 protein was expressed and purified from *Spodoptera frugiperda* Sf9 cells using a baculovirus expression system. The *Gt*ACR1 gene (GenBank Acc. KP171708, amino acid sequence 1--295) was fused with a C-terminal His8 tag and subcloned into the plasmid pFastbac1 (Invitrogen) between the cloning sites *EcoR*I and *Xba*I. Baculovirus were generated by following a standard protocol (Thermofisher, Waltham, MA). To express the *Gt*ACR1 protein, exponentially-grown S9 cells (cell density \~2×10^6^/ml) were infected by *Gt*ACR1-encoding virus in a ratio of 15:1 (v/v). All-*trans*-retinal in ethanol was added to the culture to the final concentration 5 µM. Cells were incubated for 3 days in spinner flasks at 27°C. The pink-colored cells were harvested by centrifugation using an SS34 rotor at 3000 rpm for 10 min, and the cell pellets were resuspended in Buffer A (350 mM NaCl, 5% glycerol, 20 mM HEPES, pH 7.5) with 0.1 mM phenylmethylsulfonyl fluoride (PMSF). Cell rupture was performed by 3 × passage through a high-pressure homogenizer EmulsiFlex-C3 (Avestin, Ottawa, ON). After centrifugation at low speed (5000 rpm for 10 min) to remove cell debris, membrane fractions were pelleted at 40,000 rpm for 1 hr using a Ti45 Beckman rotor. The membranes were suspended in Buffer A and solubilized with 1% dodecyl-maltoside (DDM) for 1 hr at 4°C with shaking. Undissolved content was removed after ultracentrifugation using a Ti45 rotor at 45,000 rpm for 1 hr. The supernatant supplemented with 15 mM imidazole was incubated with Ni resin (Qiagen, Hilden, Germany) for 1 hr with shaking at 4°C. The resin was step-wise washed using 15 mM and 40 mM imidazole in Buffer A supplemented with 0.03% DDM. The *Gt*ACR1 protein was eluted with 400 mM imidazole and 0.03% DDM in buffer A. The eluted protein was further purified using a Superdex Increase 10/300 GL column (GE Healthcare, Chicago, IL) equilibrated with Buffer B (350 mM NaCl, 5% glycerol, 0.03% DDM, 20 mM MES, pH 5.5). Protein fractions with an A280/A515 absorbance ratio of \~1.9 were pooled, concentrated to \~20 mg/ml using a 100 K MWCO filter, flash-frozen in liquid nitrogen and stored at −80°C until use. Molar protein concentration was calculated using the absorbance value at 515 nm divided by the extinction coefficient 45,000 M^−1^cm^−1^.

Protein crystallization {#s3-2}
-----------------------

Crystallization was carried out using the in meso approach. 40 µl of *Gt*ACR1 protein was mixed with 60 µl monoolein (MO) (Sigma, St. Louis, MO or Nu-chek, Waterville, MN), premelted at 42°C using two syringes until the mixture became transparent to form a lipidic mesophase (lipidic cubic phase; LCP). 150 nl aliquots of the protein-mesophase mixture were spotted on 96-well LCP glass sandwich plates (Molecular Dimensions, Maumee OH) and overlaid with 1.5 µl of precipitant solution using a Gryphon crystallization robot (Art Robbins, Sunnyvale, CA). The plates were covered by aluminum foil to maintain them dark and incubated at room temperature. Red-colored *Gt*ACR1 crystals of \~20 µm in size appeared after one month. The most highly diffracting crystals were obtained in a protein-mesophase mixture containing 15% 2-methyl-2,4-pentanediol (MPD), 0.1 M 2-\[(2-amino-2-oxoethyl)-(carboxymethyl)amino\]acetic acid (ADA), pH 6.0, and 0.1 M NaCl. Crystals in LCP were harvested using micromesh loops (MiTeGen, Ithaca, NY), and flash-cooled in liquid nitrogen without any additional cryoprotectant.

Data collection and processing {#s3-3}
------------------------------

X-ray diffraction data collections were performed on protein crystallography beamlines X06SA-PXI at the Swiss Light Source (SLS), Villigen, Switzerland. Data were collected with a 10 × 10 µm^2^ microfocused X-ray beam of 12.398 keV (1 Å in wavelength) at 100 K using SLS data acquisition software suites (DA+) ([@bib42]). Continuous grid-scans were used to locate crystals in frozen LCP samples ([@bib41]). The collection strategy was in steps of 0.1° at a speed of 0.1 s/step by using the EIGER 16M detector operated in continuous/shutterless data collection mode. Data were processed with XDS and scaled and merged with XSCALE ([@bib14]; [@bib15]). Four partial data sets (three with 60° wedges and one with 30° wedges) were collected, processed and merged to a final data set to 2.9 Å resolution. Data collection and processing statistics are provided in [Table 1](#table1){ref-type="table"}.

Structure determination {#s3-4}
-----------------------

The *Gt*ACR1 structure was determined using the molecular replacement (MR) method with the structure of *Chlamydomonas reinhardtii* ChR2 (PDB entry: 6EID) ([@bib35]) as the search model. The MR solution was obtained using Phaser ([@bib25]) with the TFZ to 8.7 and LLG to 221. The initial model was built using PHENIX-autobuild ([@bib1]) and further completed manually using COOT ([@bib7]). The structural refinement was performed using PHENIX ([@bib1]) The final structure has R~work~/R~free~ factors of 0.25/0.27. Refinement statistics are reported in [Table 1](#table1){ref-type="table"}. The structure factors and coordinates have been deposited in the Protein Data Bank (PDB entry code: 6EDQ). Figures of molecular structures were generated with PyMOL (<http://www.pymol.org>).

*Gt*ACR1 expression and electrophysiology {#s3-5}
-----------------------------------------

Characterization of *Gt*ACR1 mutants was performed using whole-cell photocurrent recording as previously described ([@bib32]). Briefly, the wild-type expression construct was cloned into the mammalian expression vector pcDNA3.1 (Life Technologies, Carlsbad, CA) in frame with an EYFP (enhanced yellow fluorescent protein). Mutations were introduced using a QuikChange XL site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) and verified by DNA sequencing. HEK293 (human embryonic kidney) cells were transfected using the ScreenFectA transfection reagent (Waco Chemicals USA, Richmond, VA). All-*trans*-retinal (Sigma, St. Louis, MO) was added at the final concentration 4 µM immediately after transfection. Photocurrents were recorded 48--72 hr after transfection in whole-cell voltage clamp mode at room temperature (25°C) with an Axopatch 200B amplifier (Molecular Devices, Union City, CA) and digitized with a Digidata 1440A using pClamp 10 software (both from Molecular Devices). Currents recorded in response to laser excitation or continuous light were filtered with a 10 or 2 kHz low-pass Bessel filter and digitized at 250 or 5 kHz, respectively. Patch pipettes with resistances of 2--5 MΩ were fabricated from borosilicate glass and filled with the following solution (in mM): KCl 126, MgCl~2~ 2, CaCl~2~ 0.5, EGTA 5, HEPES 25, and pH 7.4. The standard bath solution contained (in mM): NaCl 150, CaCl~2~ 1.8, MgCl~2~ 1, glucose 5, HEPES 10, pH 7.4. To test for changes in the permeability for Cl^-^, this ion in the bath was partially replaced with non-permeable aspartate (the final Cl^-^ concentration 5.6 mM, rounded to 6 mM in the figure legends). To test for changes in the permeability for H^+^, the bath pH was adjusted to 5.4, and for Na^+^, this ion in the bath was partially replaced with N-methyl-D-gluconate (NMDG) neutralized with H~2~SO~4~. (the final Na^+^ concentration 1.4 mM). In this latter case, K^+^ in the pipette was fully replaced with Na^+^, so that Na^+^ was the only monovalent metal cation present in the system. A 4 M KCl bridge was used in all measurements. Series resistance was periodically checked during recording, and measurements showing \>20% increase were discarded. The current-voltage relationships (IE curves) were measured near the expected E~rev~ to eliminate its possible changes during recording. For each cell, one value of the E~rev~ was calculated. Before averaging, the curves for individual cells were normalized to the value obtained at the most negative holding potential in the tested range. The holding potential values were corrected for liquid junction potentials calculated using the Clampex built-in LJP calculator ([@bib2]). Laser excitation was provided by a Minilite Nd:YAG laser (532 nm, pulsewidth six ns, energy 12 mJ; Continuum, San Jose, CA). A laser artifact measured with a blocked optical path was digitally subtracted from the recorded traces. For further analysis, the signals were logarithmically averaged with a custom-created computer algorithm. Curve fitting and data analysis were performed using OriginPro 2016 software (OriginLab Corporation, Northampton, MA). Continuous light pulses were provided by a Polychrome V light source (T.I.L.L. Photonics GMBH, Grafelfing, Germany) at 15 nm half-bandwidth in combination with a mechanical shutter (Uniblitz Model LS6, Vincent Associates, Rochester, NY; half-opening time 0.5 ms). The maximal quantum density at the focal plane of the 40 × objective measured with a piezo detector was 7.7 mW mm^−2^ at 515 nm. For measurements of the action spectra, short (25 ms) light pulses of the intensity in the linear response range were used at 10 nm half-bandwidth. The mean currents during the initial rise were calculated and corrected for the quantum density at each wavelength, which was measured with a calibrated photodiode. In each cell, a response to illumination at each wavelength was measured at least twice in a symmetrical fashion, first, scanning from the shortest to the longest wavelength, and then in the opposite direction. The spectral data sets obtained in all scans were pooled together (because the differences between individual cells in ACR expression levels or patch parameters were not expected to influence ACR spectral properties), normalized to the maximal value and averaged to produce the mean and sem values.

Transfection with each tested mutant variant was repeated in at least three different batches of culture, and the results obtained in cells from all batches were pooled. Batches of culture were randomly allocated for transfection with a specific mutant; no masking (blinding) was used. Individual transfected HEK293 cells were selected for patching by inspecting their tag fluorescence; non-fluorescent cells were excluded. Cells for which we could not establish a gigaohm seal or for which a gigaohm seal was lost during recording were excluded from measurements. Current traces recorded from the same cells upon repetitive light stimulation were considered as technical replicates; results obtained from different individual cells were considered as biological replicates. In experiments with laser excitation, 10 technical replicates were averaged to yield a single mean trace for each cell; in experiments with continuous light pulses, a single trace was recorded in each cell. The baseline measured before illumination was subtracted using Clampfit software (a subroutine of pClamp). The same software was used to measure the peak current amplitude with a cursor. The raw data obtained in individual cells are shown as open diamonds and listed in the corresponding source data tables. Sample size was estimated from previous experience and published work on a similar subject, as recommended by the NIH guidelines ([@bib6]). No outliers were excluded from calculation of mean values. Normality of the data was not assumed, and therefore non-parametric statistical tests were used as implemented in OriginPro 2016 software; P values \> 0.05 were considered not significant. The results of statistical hypothesis testing are shown in [Tables 2](#table2){ref-type="table"}--[4](#table4){ref-type="table"}. When no specific statistical hypothesis was tested, descriptive statistical analysis was applied.

Cell lines {#s3-6}
----------

Only commercially available cell lines authenticated by the vendors (Sf9 from Sigma Aldrich and HEK293 from ATCC) were used; no cell lines from the list of commonly misidentified cell lines were used. The absence of micoplasma contamination was verified by Visual-PCR mycoplasma detection kit (GM Biosciences, Frederick, MD).

Data availability {#s3-7}
-----------------

Atomic coordinates and structure factors for the reported crystal structure have been deposited with the Protein Data Bank (PDB) under the accession code 6EDQ.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Crystal structure of a natural light-gated anion channelrhodopsin\" for consideration by *eLife*. Your article has been reviewed by Richard Aldrich as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor Dr. Sriram Subramaniam has drafted this decision to help you prepare a revised submission.

All of the reviewers agreed that this is a very well executed manuscript with convincing experimental evidence. The reviewers also recognized that your manuscript reports the crystal structure of the full-length protein, independently verifying the previously obtained structure of a truncated form of this channel, thus creating a firm basis for further optimization of a potent neuron-silencing optogenetic tool.

Essential revisions:

1\) Effects of crystal packing on the structure that may arise from different crystallization constructs.

2\) The conclusion that (i) the retinylidene Schiff base protonated configuration is maintained when the channel is open and (ii) Schiff base controls gating and also serves as a direct mediator for anion flux is not directly demonstrated. It would be good to address this if possible.

3\) Kinetic analysis of channel open/close events is not presented. As a result, one cannot distinguish between different loss-of-function mutant phenotypes affecting C1, C2 and C3 regions.

4\) Spectral characteristics of mutants are lacking.

5\) Figure 1---figure supplement 1 should include spectral and functional (anion transport) validation data for natural vs recombinant purified ACR1 proteins.

6\) Subsection "Ion pathway constrictions": "dark-grown crystals is presumably the dark (closed) state of the channel protein", is this correct?

7\) Subsection "Ion pathway constrictions": What is the rationale for choice of Glu for site-specific replacements? Why was there no consideration of gain-of-function testing? Could the use of Glu simply change electrochemical repulsion of anion flux rather than physically opening the channel?

8\) Did the M105E mutant cause photochemical perturbation as this residue is closed to Schiff base linkage?

9\) If possible, please show conductance, current/voltage relationships and reversal potentials for the crystalized construct, native protein and individual mutants as supplementary data.

a\) Absorption spectra and kinetics of wild-type GtACR1 and mutants should be shown in the supplement.

b\) Especially for the Schiff base protonation in wild-type and mutants, it would be good to present detailed spectroscopic data.

c\) The authors should include a discussion paragraph highlighting key unique features that distinguish their work from the work of Kim et al., (2018).

10.7554/eLife.41741.040

Author response

> All of the reviewers agreed that this is a very well executed manuscript with convincing experimental evidence. The reviewers also recognized that your manuscript reports the crystal structure of the full-length protein, independently verifying the previously obtained structure of a truncated form of this channel, thus creating a firm basis for further optimization of a potent neuron-silencing optogenetic tool.
>
> Essential revisions:
>
> 1\) Effects of crystal packing on the structure that may arise from different crystallization constructs.

We have added a subsection "Comparison with the recently published *Gt*ACR1 structure" at the end of Results and Discussion section. The two structures show an extremely high similarity with a marginal RMSD value of \~0.4 Å. All seven transmembrane helices are very well superimposed between the two structures. We added a figure showing their superimposition (Figure 5---figure supplement 4). Neither the different constructs nor different crystal packing gave rise to any large differences in the protein structure.

> 2\) The conclusion that (i) the retinylidene Schiff base protonated configuration is maintained when the channel is open and (ii) Schiff base controls gating and also serves as a direct mediator for anion flux is not directly demonstrated. It would be good to address this if possible.

We suggest the interesting possibility of direct participation of the protonated Schiff base based on several observations and have expanded the previous paragraph in the text, which now reads as follows:

"The location of the protonated Schiff base (PSB), centered within the anion path in *Gt*ACR1, suggests that it may play a direct role in anion translocation in the open channel state. Consistent with this idea is that the PSB is only partially neutralized by its D234 counterion because the counterion is weakened by its interaction with the 2 tyrosinyl residues. Therefore, the PSB presents a partial positive charge capable of transient reversible interaction with Cl^-^ ions in a channel that is largely lined by small polar and hydrophobic aliphatic residues. Supporting a possible direct role of the PSB, late deprotonation of the Schiff base after channel opening occurs in all three ACRs so far examined: *Gt*ACR1 and *Gt*ACR2 (Sineshchekov et al., 2016) and *Psu*ACR1 (Wietek et al., 2016), yet Schiff base deprotonation after channel opening is not known to occur in any CCR. Further indicating an essential role of the protonated form, the mutant S97E, in which a potential Schiff base proton acceptor is placed at the corresponding position in *Gt*ACR1 as in CCRs and many other microbial rhodopsins, exhibits (i) appearance of fast Schiff base deprotonation, and (ii) a \>30-fold suppression of the amplitude of the chloride photocurrent (Sineshchekov et al., 2016). Furthermore, the double mutation Y207F/Y72F, expected to release inhibition of D234 as a proton acceptor, decreased the photocurrent amplitude to a negligible value (Figure 5D)."

> 3\) Kinetic analysis of channel open/close events is not presented. As a result, one cannot distinguish between different loss-of function mutant phenotypes affecting C1, C2 and C3 regions.

We have added a new figure (Figure 3---figure supplement 2) to the revision showing photocurrent traces from the mutants in the C1 and C3 regions recorded under single-turnover conditions (i.e. upon laser flash excitation), and the results of their multiexponential fitting and the time constants of the individual kinetic components. Kinetics of the photocurrents from the C2 mutants could not be analyzed because of their greatly suppressed amplitude (Figure 3G).

> 4\) Spectral characteristics of mutants are lacking.

Spectral characteristics of the wild-type and mutants in key sites are presented in Sineshchekov et al., 2016 referenced in this manuscript. We have added with discussion in the revision two new figures (Figure 4---figure supplement 1 and Figure 5---figure supplement 1) showing the action spectra of photocurrents generated by the F150G, Y72F and Y207F mutants.

> 5\) Figure 1---figure supplement 1 should include spectral and functional (anion transport) validation data for natural Vs recombinant purified ACR1 proteins.

Unlike bacteriorhodopsin and several other type 1 rhodopsins, channelrhodopsins are present in algal cells at very low concentrations (e.g. Govorunova et al., (2004)), so that not only purification of natural channelrhodopsins from algal cells, but also their spectroscopic detection in situ are technically not feasible. Therefore, only recombinant *Gt*ACR1 expressed in heterologous systems have so far been characterized (Sineshchekov et al., 2015; 2016 referred to in this manuscript and other articles referred to in Govorunova et al., 2017).

The wild-type expression construct (encoding residues 1-295) used for crystallization in this study was the same as used in our previous electrophysiological recordings in cultured animal cells and as used for spectroscopic and photochemical characterization of the protein expressed and purified from *Pichia* (Sineshchekov et al., 2015; 2016; Govorunova et al., 2017, and references therein). The wild-type photocurrent action spectrum in HEK293 cells is superimposable with the absorption spectrum from *Pichia*-expressed purified *Gt*ACR1 (Sineshchekov et al., 2015, 2016) which is identical to the absorption spectrum of purified insect (Sf9) cell-expressed GtACR1 used for crystallization.

For clarification in the revised manuscript we show the absorption spectrum of the purified crystallized construct in Figure 1---figure supplement 1C, and a representative photocurrent trace recorded upon laser flash excitation from this construct expressed in HEK293 is shown as a dashed line in Figure 3---figure supplements 1 and 2, Figure 4---figure supplement 1 and Figure 5---figure supplement 1.

> 6\) Subsection "Ion pathway constrictions": "dark-grown crystals is presumably the dark (closed) state of the channel protein", is this correct?

We expect it to be closed because the crystals are formed in the dark and wild-type *Gt*ACR1 in membranes is in a tightly closed-channel conformation in the dark. The structure itself is consistent with the dark (closed) state. The intramolecular tunnel that traverses the protein is narrowly constricted at positions C1, C2, and C3 and further potentially blocked by the retinylidene Schiff base at C2 and by the extracellular cap.

> 7\) Subsection "Ion pathway constrictions": What is the rationale for choice of Glu for site-specific replacements? Why was there no consideration of gain-of-function testing? Could the use of Glu simply change electrochemical repulsion of anion flux rather than physically opening the channel?

Glu was initially as a substituent because two of the C1 residues correspond in position to highly conserved Glu residues in CCRs known to be important in cation conductance. Second, the negative charge and its bulky sidechain are expected to block the anion channel thus decreasing or eliminating photocurrents. We have not suggested that introduction of Glu would physically open the channel; rather we expected that it would block, and, as Figure 3G shows, this expectation turned out to be true for C2 and C3 constrictions, distinguishing them from C1 residues. For clarification we expanded the paragraph on the Glu scanning of constriction sites in the revision as follows:

"We chose Glu as a substituent because two of the constriction residues, A61 and A75, correspond to the highly conserved Glu residues in CCRs (E122/E83 and E136/E97 in C1C2/*Cr*ChR2, respectively), and because neutralization of E83 was required for elimination of the residual H^+^ permeability in Cl^-^-conducting CCR mutants (Berndt et al., 2016; Wietek et al., 2015). We also hypothesized that the bulky negatively charged Glu side chain would block the *Gt*ACR1 channel when placed in the ion conduction pathway. Indeed, perturbation of any residues at C2 or C3 greatly reduced or eliminated the photocurrents, while effects of most mutations (except A75E) at the C1 position were negligible (Figure 3G), suggesting that in the open conformation the channel is wider in the extracellular portion and more narrow in its central and intracellular stretches."

It is not clear to us what "gain-of-function testing" is referred to in the question. Recording and analysis of photocurrents reveals both loss- and gain-of-function effects of mutations. In this regard, of all mutants we have tested in this study, none exhibited larger currents than the wild type (Figures 3G and Figure 5D).

> 8\) Did the M105E mutant cause photochemical perturbation as this residue is closed to Schiff base linkage?

M105 is a constituent of the retinal binding pocket and is located adjacent to the Schiff base with a distance of 4.6 Å, so it is highly likely that its perturbation as well as that of other residues near the Schiff base would influence the photochemical reaction cycle. Study of photoactive site residues will be of interest, but we regard analysis of mutant photocycles as beyond the scope of this report.

> 9\) If possible, please show conductance, current/voltage relationships and reversal potentials for the crystalized construct, native protein and individual mutants as supplementary data.

The crystallized construct and several of its mutants have been characterized in our previous publications (Sineshchekov et al., 2015 and 2016) referred to in this manuscript. As explained above, isolation of native *Gt*ACR1 protein from algal cells is not feasible. The conductance data (mean photocurrent amplitudes) of the mutants made in this study are shown in Figures 3G and 5D. In the revision we have added new figures (Figure 3---figure supplement 3 and Figure 3---figure supplement 4) showing the current-voltage relationships (IE curves) and reversal potentials for wild-type *Gt*ACR1 and mutants and discussion of these data in the text.

> a\) Absorption spectra and kinetics of wild-type GtACR1 and mutants should be shown in the supplement.

The absorption spectrum of the crystallized construct is shown in Figure 1---figure supplement 1C. A representative photocurrent trace recorded upon laser flash excitation from this construct expressed in HEK293 is shown as a dashed line in Figure 3 ---figure supplements 1 and 2, Figure 4 ---figure supplement 1 and Figure 5---figure supplement 1. Detailed analyses of wild-type current kinetics and photochemical reaction cycle transition kinetics have been reported in Sineshchekov et al., 2015 and 2016, respectively, referred to in this manuscript.

We have added to the revision four new figures (Figure 3---figure supplements 1 and 2, Figure 5---figure supplement 2 and Figure 5---figure supplement 3) showing the currents kinetics recorded under single-turnover conditions from the mutants described in this study, along with the results of their multiexponential fitting and numerical values of the derived time constants of individual current components. Two new figures (Figure---figure supplement 1 and Figure 5---figure supplement 1) have been added to the revision showing the action spectra of photocurrents generated by the mutants. Descriptions of these results have been added where these new figures are referred to in the text.

> b\) Especially for the Schiff base protonation in wild-type and mutants, it would be good to present detailed spectroscopic data.

Detailed spectroscopic characterization of wild-type *Gt*ACR1 and several of its mutants has already been presented in two PNAS articles (Sineshchekov et al., 2015 and 2016) referred to in this study. We have added with discussion in the revision two new figures (Figure 4---figure supplement 1 and Figure 5---figure supplement 1) showing the action spectra of photocurrents generated by the F160G, Y72F and Y207F mutants.

> c\) The authors should include a discussion paragraph highlighting key unique features that distinguish their work from the work of Kim et al., (2018).

We thank the Editors for the opportunity to add this informative section. We have added a subsection ""Comparison with the recently published *Gt*ACR1 structure" at the end of Results and Discussion section. We believe that overall the independent analyses of the structures by both our groups provide complimentary information creating a firm basis for elucidating the functional mechanism and for further optimization of *Gt*ACR1 as a potent neuron-silencing optogenetic tool.
